Login with ORCID

assertion

Full identifier: http://purl.org/np/RAOE99VP_HbvtZOrGDBDGP2izlwpCwpqohyOcubyj2CYI#assertion

Minted in Nanopublication

 RAOE99VP_H comment approve/disapprove edit as derived nanopublication

This is a local identifier minted within the nanopublication. http://purl.org/np/RAOE99VP_H...#sig
sig
http://purl.org/nanopub/x/hasSignatureTarget has as target This is the identifier for this whole nanopublication. http://purl.org/np/RAOE99VP_H... this nanopublication .
This is a local identifier minted within the nanopublication. http://purl.org/np/RAOE99VP_H...#sig
sig
http://purl.org/nanopub/x/hasAlgorithm has the algorithm (this is a literal)
.

References

Nanopublication Part Subject Predicate Object Published By Published On
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
assertion
Elif Ozkan
2022-10-13T12:18:06.846Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
assertion
2022-10-13T12:18:06.846456
Elif Ozkan
2022-10-13T12:18:06.846Z
links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance
assertion
Abacavir is indicated in combination with other anti-retroviral agents for the treatment of HIV-1 infection. It is available in a combination product alongside dolutegravir and lamivudine for the. treatment of adult and pediatric patients with HIV--1 who weigh. 10 kg who weigh ≥10 kg are considered to be patients with the disease. Adults and children who weigh more than 10 kg are recommended to take the drug.
Elif Ozkan
2022-10-13T12:18:06.846Z

Raw

TriG(txt), JSON-LD(txt), N-Quads(txt), XML(txt)